CCL2 and Parkinson disease: The Ccl2-2518A allele is associated with lower MCP-1 production and reduced transcriptional activity following IL-1β stimulation [84], and in genetic epidemiological studies, possession of this allele is associated with a delayed onset of PD compared with patients expressing the Ccl2-2518G allele [85].